REZOLUTE INC. NEW DL-,001 |
USA |
Gesundheit |
US76200L3096 / A2QEWP |
6HV1 (Frankfurt) / RZLT (NASDAQ) |
FRA:6HV1, ETR:6HV1, 6HV1:GR, NASDAQ:RZLT |
- |
https://rezolutebio.com/ |
Rezolute, Inc. is a clinical-stage biopharmaceutic..
>Volltext.. |
483.04 Mio. EUR |
404.42 Mio. EUR |
- |
-66.18 Mio. EUR |
-62.65 Mio. EUR |
-0.99 EUR |
1.52 Mio. EUR |
12.53 Mio. EUR |
-56.3 Mio. EUR |
8.25 |
- |
-25.07% |
- |
- |
- |
- |
REZOLUTE |
21.08.25 |
|
||||
|